Global Tumor NGS Detection Market Growth (Status and Outlook) 2026-2032
The global Tumor NGS Detection market size is predicted to grow from US$ 2711 million in 2025 to US$ 7697 million in 2032; it is expected to grow at a CAGR of 16.4% from 2026 to 2032.
The main purpose of NGS is to discover clinically treatable genetic variants and guide patient treatment.
United States market for Tumor NGS Detection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Tumor NGS Detection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Tumor NGS Detection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Tumor NGS Detection players cover Agilent, Thermo Fisher Scientific, BGI Group, Roche Foundation Medicine, Sinopharm Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Tumor NGS Detection Industry Forecast” looks at past sales and reviews total world Tumor NGS Detection sales in 2025, providing a comprehensive analysis by region and market sector of projected Tumor NGS Detection sales for 2026 through 2032. With Tumor NGS Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor NGS Detection industry.
This Insight Report provides a comprehensive analysis of the global Tumor NGS Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tumor NGS Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor NGS Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor NGS Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor NGS Detection.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor NGS Detection market by product type, application, key players and key regions and countries.
Segmentation by Type:
The main purpose of NGS is to discover clinically treatable genetic variants and guide patient treatment.
United States market for Tumor NGS Detection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Tumor NGS Detection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Tumor NGS Detection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Tumor NGS Detection players cover Agilent, Thermo Fisher Scientific, BGI Group, Roche Foundation Medicine, Sinopharm Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Tumor NGS Detection Industry Forecast” looks at past sales and reviews total world Tumor NGS Detection sales in 2025, providing a comprehensive analysis by region and market sector of projected Tumor NGS Detection sales for 2026 through 2032. With Tumor NGS Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor NGS Detection industry.
This Insight Report provides a comprehensive analysis of the global Tumor NGS Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tumor NGS Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor NGS Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor NGS Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor NGS Detection.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor NGS Detection market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Medical Equipment
- Consumables
- Companion Diagnostics
- Early Cancer Screening
- Drug Discovery
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Agilent
- Thermo Fisher Scientific
- BGI Group
- Roche Foundation Medicine
- Sinopharm Group
- Fosunpharma
- Novogene
- Geneseeq
- AmoyDx
- Burning Rock Medicine
- Perkin Elmer
- Qiagen NV
- Partek
- Illumina Inc.
- Pacific Biosciences of California Inc.
- Life Technologies Corporation
- GTH.O
- Paradigm Diagnostics
- Oxford Nanopore Technologies Ltd.
- Eurofins Scientific S.E.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor NGS Detection Market Size (2021-2032)
2.1.2 Tumor NGS Detection Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Tumor NGS Detection by Country/Region (2021, 2025 & 2032)
2.2 Tumor NGS Detection Segment by Type
2.2.1 Medical Equipment
2.2.2 Consumables
2.2.3 Tumor NGS Detection Market Size by Type
2.2.3.1 Tumor NGS Detection Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Tumor NGS Detection Market Size Market Share by Type (2021-2026)
2.3 Tumor NGS Detection Segment by Application
2.3.1 Companion Diagnostics
2.3.2 Early Cancer Screening
2.3.3 Drug Discovery
2.3.4 Other
2.3.5 Tumor NGS Detection Market Size by Application
2.3.5.1 Tumor NGS Detection Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Tumor NGS Detection Market Size Market Share by Application (2021-2026)
3 TUMOR NGS DETECTION MARKET SIZE BY PLAYER
3.1 Tumor NGS Detection Market Size Market Share by Player
3.1.1 Global Tumor NGS Detection Revenue by Player (2021-2026)
3.1.2 Global Tumor NGS Detection Revenue Market Share by Player (2021-2026)
3.2 Global Tumor NGS Detection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUMOR NGS DETECTION BY REGION
4.1 Tumor NGS Detection Market Size by Region (2021-2026)
4.2 Global Tumor NGS Detection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tumor NGS Detection Market Size Growth (2021-2026)
4.4 APAC Tumor NGS Detection Market Size Growth (2021-2026)
4.5 Europe Tumor NGS Detection Market Size Growth (2021-2026)
4.6 Middle East & Africa Tumor NGS Detection Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Tumor NGS Detection Market Size by Country (2021-2026)
5.2 Americas Tumor NGS Detection Market Size by Type (2021-2026)
5.3 Americas Tumor NGS Detection Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor NGS Detection Market Size by Region (2021-2026)
6.2 APAC Tumor NGS Detection Market Size by Type (2021-2026)
6.3 APAC Tumor NGS Detection Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tumor NGS Detection Market Size by Country (2021-2026)
7.2 Europe Tumor NGS Detection Market Size by Type (2021-2026)
7.3 Europe Tumor NGS Detection Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor NGS Detection by Region (2021-2026)
8.2 Middle East & Africa Tumor NGS Detection Market Size by Type (2021-2026)
8.3 Middle East & Africa Tumor NGS Detection Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUMOR NGS DETECTION MARKET FORECAST
10.1 Global Tumor NGS Detection Forecast by Region (2027-2032)
10.1.1 Global Tumor NGS Detection Forecast by Region (2027-2032)
10.1.2 Americas Tumor NGS Detection Forecast
10.1.3 APAC Tumor NGS Detection Forecast
10.1.4 Europe Tumor NGS Detection Forecast
10.1.5 Middle East & Africa Tumor NGS Detection Forecast
10.2 Americas Tumor NGS Detection Forecast by Country (2027-2032)
10.2.1 United States Market Tumor NGS Detection Forecast
10.2.2 Canada Market Tumor NGS Detection Forecast
10.2.3 Mexico Market Tumor NGS Detection Forecast
10.2.4 Brazil Market Tumor NGS Detection Forecast
10.3 APAC Tumor NGS Detection Forecast by Region (2027-2032)
10.3.1 China Tumor NGS Detection Market Forecast
10.3.2 Japan Market Tumor NGS Detection Forecast
10.3.3 Korea Market Tumor NGS Detection Forecast
10.3.4 Southeast Asia Market Tumor NGS Detection Forecast
10.3.5 India Market Tumor NGS Detection Forecast
10.3.6 Australia Market Tumor NGS Detection Forecast
10.4 Europe Tumor NGS Detection Forecast by Country (2027-2032)
10.4.1 Germany Market Tumor NGS Detection Forecast
10.4.2 France Market Tumor NGS Detection Forecast
10.4.3 UK Market Tumor NGS Detection Forecast
10.4.4 Italy Market Tumor NGS Detection Forecast
10.4.5 Russia Market Tumor NGS Detection Forecast
10.5 Middle East & Africa Tumor NGS Detection Forecast by Region (2027-2032)
10.5.1 Egypt Market Tumor NGS Detection Forecast
10.5.2 South Africa Market Tumor NGS Detection Forecast
10.5.3 Israel Market Tumor NGS Detection Forecast
10.5.4 Turkey Market Tumor NGS Detection Forecast
10.6 Global Tumor NGS Detection Forecast by Type (2027-2032)
10.7 Global Tumor NGS Detection Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Tumor NGS Detection Forecast
11 KEY PLAYERS ANALYSIS
11.1 Agilent
11.1.1 Agilent Company Information
11.1.2 Agilent Tumor NGS Detection Product Offered
11.1.3 Agilent Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Agilent Main Business Overview
11.1.5 Agilent Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Tumor NGS Detection Product Offered
11.2.3 Thermo Fisher Scientific Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 BGI Group
11.3.1 BGI Group Company Information
11.3.2 BGI Group Tumor NGS Detection Product Offered
11.3.3 BGI Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 BGI Group Main Business Overview
11.3.5 BGI Group Latest Developments
11.4 Roche Foundation Medicine
11.4.1 Roche Foundation Medicine Company Information
11.4.2 Roche Foundation Medicine Tumor NGS Detection Product Offered
11.4.3 Roche Foundation Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Roche Foundation Medicine Main Business Overview
11.4.5 Roche Foundation Medicine Latest Developments
11.5 Sinopharm Group
11.5.1 Sinopharm Group Company Information
11.5.2 Sinopharm Group Tumor NGS Detection Product Offered
11.5.3 Sinopharm Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sinopharm Group Main Business Overview
11.5.5 Sinopharm Group Latest Developments
11.6 Fosunpharma
11.6.1 Fosunpharma Company Information
11.6.2 Fosunpharma Tumor NGS Detection Product Offered
11.6.3 Fosunpharma Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fosunpharma Main Business Overview
11.6.5 Fosunpharma Latest Developments
11.7 Novogene
11.7.1 Novogene Company Information
11.7.2 Novogene Tumor NGS Detection Product Offered
11.7.3 Novogene Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Novogene Main Business Overview
11.7.5 Novogene Latest Developments
11.8 Geneseeq
11.8.1 Geneseeq Company Information
11.8.2 Geneseeq Tumor NGS Detection Product Offered
11.8.3 Geneseeq Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Geneseeq Main Business Overview
11.8.5 Geneseeq Latest Developments
11.9 AmoyDx
11.9.1 AmoyDx Company Information
11.9.2 AmoyDx Tumor NGS Detection Product Offered
11.9.3 AmoyDx Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 AmoyDx Main Business Overview
11.9.5 AmoyDx Latest Developments
11.10 Burning Rock Medicine
11.10.1 Burning Rock Medicine Company Information
11.10.2 Burning Rock Medicine Tumor NGS Detection Product Offered
11.10.3 Burning Rock Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Burning Rock Medicine Main Business Overview
11.10.5 Burning Rock Medicine Latest Developments
11.11 Perkin Elmer
11.11.1 Perkin Elmer Company Information
11.11.2 Perkin Elmer Tumor NGS Detection Product Offered
11.11.3 Perkin Elmer Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Perkin Elmer Main Business Overview
11.11.5 Perkin Elmer Latest Developments
11.12 Qiagen NV
11.12.1 Qiagen NV Company Information
11.12.2 Qiagen NV Tumor NGS Detection Product Offered
11.12.3 Qiagen NV Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Qiagen NV Main Business Overview
11.12.5 Qiagen NV Latest Developments
11.13 Partek
11.13.1 Partek Company Information
11.13.2 Partek Tumor NGS Detection Product Offered
11.13.3 Partek Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Partek Main Business Overview
11.13.5 Partek Latest Developments
11.14 Illumina Inc.
11.14.1 Illumina Inc. Company Information
11.14.2 Illumina Inc. Tumor NGS Detection Product Offered
11.14.3 Illumina Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Illumina Inc. Main Business Overview
11.14.5 Illumina Inc. Latest Developments
11.15 Pacific Biosciences of California Inc.
11.15.1 Pacific Biosciences of California Inc. Company Information
11.15.2 Pacific Biosciences of California Inc. Tumor NGS Detection Product Offered
11.15.3 Pacific Biosciences of California Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Pacific Biosciences of California Inc. Main Business Overview
11.15.5 Pacific Biosciences of California Inc. Latest Developments
11.16 Life Technologies Corporation
11.16.1 Life Technologies Corporation Company Information
11.16.2 Life Technologies Corporation Tumor NGS Detection Product Offered
11.16.3 Life Technologies Corporation Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Life Technologies Corporation Main Business Overview
11.16.5 Life Technologies Corporation Latest Developments
11.17 GTH.O
11.17.1 GTH.O Company Information
11.17.2 GTH.O Tumor NGS Detection Product Offered
11.17.3 GTH.O Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 GTH.O Main Business Overview
11.17.5 GTH.O Latest Developments
11.18 Paradigm Diagnostics
11.18.1 Paradigm Diagnostics Company Information
11.18.2 Paradigm Diagnostics Tumor NGS Detection Product Offered
11.18.3 Paradigm Diagnostics Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Paradigm Diagnostics Main Business Overview
11.18.5 Paradigm Diagnostics Latest Developments
11.19 Oxford Nanopore Technologies Ltd.
11.19.1 Oxford Nanopore Technologies Ltd. Company Information
11.19.2 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Offered
11.19.3 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Oxford Nanopore Technologies Ltd. Main Business Overview
11.19.5 Oxford Nanopore Technologies Ltd. Latest Developments
11.20 Eurofins Scientific S.E.
11.20.1 Eurofins Scientific S.E. Company Information
11.20.2 Eurofins Scientific S.E. Tumor NGS Detection Product Offered
11.20.3 Eurofins Scientific S.E. Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Eurofins Scientific S.E. Main Business Overview
11.20.5 Eurofins Scientific S.E. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor NGS Detection Market Size (2021-2032)
2.1.2 Tumor NGS Detection Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Tumor NGS Detection by Country/Region (2021, 2025 & 2032)
2.2 Tumor NGS Detection Segment by Type
2.2.1 Medical Equipment
2.2.2 Consumables
2.2.3 Tumor NGS Detection Market Size by Type
2.2.3.1 Tumor NGS Detection Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Tumor NGS Detection Market Size Market Share by Type (2021-2026)
2.3 Tumor NGS Detection Segment by Application
2.3.1 Companion Diagnostics
2.3.2 Early Cancer Screening
2.3.3 Drug Discovery
2.3.4 Other
2.3.5 Tumor NGS Detection Market Size by Application
2.3.5.1 Tumor NGS Detection Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Tumor NGS Detection Market Size Market Share by Application (2021-2026)
3 TUMOR NGS DETECTION MARKET SIZE BY PLAYER
3.1 Tumor NGS Detection Market Size Market Share by Player
3.1.1 Global Tumor NGS Detection Revenue by Player (2021-2026)
3.1.2 Global Tumor NGS Detection Revenue Market Share by Player (2021-2026)
3.2 Global Tumor NGS Detection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUMOR NGS DETECTION BY REGION
4.1 Tumor NGS Detection Market Size by Region (2021-2026)
4.2 Global Tumor NGS Detection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tumor NGS Detection Market Size Growth (2021-2026)
4.4 APAC Tumor NGS Detection Market Size Growth (2021-2026)
4.5 Europe Tumor NGS Detection Market Size Growth (2021-2026)
4.6 Middle East & Africa Tumor NGS Detection Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Tumor NGS Detection Market Size by Country (2021-2026)
5.2 Americas Tumor NGS Detection Market Size by Type (2021-2026)
5.3 Americas Tumor NGS Detection Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor NGS Detection Market Size by Region (2021-2026)
6.2 APAC Tumor NGS Detection Market Size by Type (2021-2026)
6.3 APAC Tumor NGS Detection Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tumor NGS Detection Market Size by Country (2021-2026)
7.2 Europe Tumor NGS Detection Market Size by Type (2021-2026)
7.3 Europe Tumor NGS Detection Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor NGS Detection by Region (2021-2026)
8.2 Middle East & Africa Tumor NGS Detection Market Size by Type (2021-2026)
8.3 Middle East & Africa Tumor NGS Detection Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUMOR NGS DETECTION MARKET FORECAST
10.1 Global Tumor NGS Detection Forecast by Region (2027-2032)
10.1.1 Global Tumor NGS Detection Forecast by Region (2027-2032)
10.1.2 Americas Tumor NGS Detection Forecast
10.1.3 APAC Tumor NGS Detection Forecast
10.1.4 Europe Tumor NGS Detection Forecast
10.1.5 Middle East & Africa Tumor NGS Detection Forecast
10.2 Americas Tumor NGS Detection Forecast by Country (2027-2032)
10.2.1 United States Market Tumor NGS Detection Forecast
10.2.2 Canada Market Tumor NGS Detection Forecast
10.2.3 Mexico Market Tumor NGS Detection Forecast
10.2.4 Brazil Market Tumor NGS Detection Forecast
10.3 APAC Tumor NGS Detection Forecast by Region (2027-2032)
10.3.1 China Tumor NGS Detection Market Forecast
10.3.2 Japan Market Tumor NGS Detection Forecast
10.3.3 Korea Market Tumor NGS Detection Forecast
10.3.4 Southeast Asia Market Tumor NGS Detection Forecast
10.3.5 India Market Tumor NGS Detection Forecast
10.3.6 Australia Market Tumor NGS Detection Forecast
10.4 Europe Tumor NGS Detection Forecast by Country (2027-2032)
10.4.1 Germany Market Tumor NGS Detection Forecast
10.4.2 France Market Tumor NGS Detection Forecast
10.4.3 UK Market Tumor NGS Detection Forecast
10.4.4 Italy Market Tumor NGS Detection Forecast
10.4.5 Russia Market Tumor NGS Detection Forecast
10.5 Middle East & Africa Tumor NGS Detection Forecast by Region (2027-2032)
10.5.1 Egypt Market Tumor NGS Detection Forecast
10.5.2 South Africa Market Tumor NGS Detection Forecast
10.5.3 Israel Market Tumor NGS Detection Forecast
10.5.4 Turkey Market Tumor NGS Detection Forecast
10.6 Global Tumor NGS Detection Forecast by Type (2027-2032)
10.7 Global Tumor NGS Detection Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Tumor NGS Detection Forecast
11 KEY PLAYERS ANALYSIS
11.1 Agilent
11.1.1 Agilent Company Information
11.1.2 Agilent Tumor NGS Detection Product Offered
11.1.3 Agilent Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Agilent Main Business Overview
11.1.5 Agilent Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Tumor NGS Detection Product Offered
11.2.3 Thermo Fisher Scientific Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 BGI Group
11.3.1 BGI Group Company Information
11.3.2 BGI Group Tumor NGS Detection Product Offered
11.3.3 BGI Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 BGI Group Main Business Overview
11.3.5 BGI Group Latest Developments
11.4 Roche Foundation Medicine
11.4.1 Roche Foundation Medicine Company Information
11.4.2 Roche Foundation Medicine Tumor NGS Detection Product Offered
11.4.3 Roche Foundation Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Roche Foundation Medicine Main Business Overview
11.4.5 Roche Foundation Medicine Latest Developments
11.5 Sinopharm Group
11.5.1 Sinopharm Group Company Information
11.5.2 Sinopharm Group Tumor NGS Detection Product Offered
11.5.3 Sinopharm Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sinopharm Group Main Business Overview
11.5.5 Sinopharm Group Latest Developments
11.6 Fosunpharma
11.6.1 Fosunpharma Company Information
11.6.2 Fosunpharma Tumor NGS Detection Product Offered
11.6.3 Fosunpharma Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fosunpharma Main Business Overview
11.6.5 Fosunpharma Latest Developments
11.7 Novogene
11.7.1 Novogene Company Information
11.7.2 Novogene Tumor NGS Detection Product Offered
11.7.3 Novogene Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Novogene Main Business Overview
11.7.5 Novogene Latest Developments
11.8 Geneseeq
11.8.1 Geneseeq Company Information
11.8.2 Geneseeq Tumor NGS Detection Product Offered
11.8.3 Geneseeq Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Geneseeq Main Business Overview
11.8.5 Geneseeq Latest Developments
11.9 AmoyDx
11.9.1 AmoyDx Company Information
11.9.2 AmoyDx Tumor NGS Detection Product Offered
11.9.3 AmoyDx Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 AmoyDx Main Business Overview
11.9.5 AmoyDx Latest Developments
11.10 Burning Rock Medicine
11.10.1 Burning Rock Medicine Company Information
11.10.2 Burning Rock Medicine Tumor NGS Detection Product Offered
11.10.3 Burning Rock Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Burning Rock Medicine Main Business Overview
11.10.5 Burning Rock Medicine Latest Developments
11.11 Perkin Elmer
11.11.1 Perkin Elmer Company Information
11.11.2 Perkin Elmer Tumor NGS Detection Product Offered
11.11.3 Perkin Elmer Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Perkin Elmer Main Business Overview
11.11.5 Perkin Elmer Latest Developments
11.12 Qiagen NV
11.12.1 Qiagen NV Company Information
11.12.2 Qiagen NV Tumor NGS Detection Product Offered
11.12.3 Qiagen NV Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Qiagen NV Main Business Overview
11.12.5 Qiagen NV Latest Developments
11.13 Partek
11.13.1 Partek Company Information
11.13.2 Partek Tumor NGS Detection Product Offered
11.13.3 Partek Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Partek Main Business Overview
11.13.5 Partek Latest Developments
11.14 Illumina Inc.
11.14.1 Illumina Inc. Company Information
11.14.2 Illumina Inc. Tumor NGS Detection Product Offered
11.14.3 Illumina Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Illumina Inc. Main Business Overview
11.14.5 Illumina Inc. Latest Developments
11.15 Pacific Biosciences of California Inc.
11.15.1 Pacific Biosciences of California Inc. Company Information
11.15.2 Pacific Biosciences of California Inc. Tumor NGS Detection Product Offered
11.15.3 Pacific Biosciences of California Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Pacific Biosciences of California Inc. Main Business Overview
11.15.5 Pacific Biosciences of California Inc. Latest Developments
11.16 Life Technologies Corporation
11.16.1 Life Technologies Corporation Company Information
11.16.2 Life Technologies Corporation Tumor NGS Detection Product Offered
11.16.3 Life Technologies Corporation Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Life Technologies Corporation Main Business Overview
11.16.5 Life Technologies Corporation Latest Developments
11.17 GTH.O
11.17.1 GTH.O Company Information
11.17.2 GTH.O Tumor NGS Detection Product Offered
11.17.3 GTH.O Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 GTH.O Main Business Overview
11.17.5 GTH.O Latest Developments
11.18 Paradigm Diagnostics
11.18.1 Paradigm Diagnostics Company Information
11.18.2 Paradigm Diagnostics Tumor NGS Detection Product Offered
11.18.3 Paradigm Diagnostics Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Paradigm Diagnostics Main Business Overview
11.18.5 Paradigm Diagnostics Latest Developments
11.19 Oxford Nanopore Technologies Ltd.
11.19.1 Oxford Nanopore Technologies Ltd. Company Information
11.19.2 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Offered
11.19.3 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Oxford Nanopore Technologies Ltd. Main Business Overview
11.19.5 Oxford Nanopore Technologies Ltd. Latest Developments
11.20 Eurofins Scientific S.E.
11.20.1 Eurofins Scientific S.E. Company Information
11.20.2 Eurofins Scientific S.E. Tumor NGS Detection Product Offered
11.20.3 Eurofins Scientific S.E. Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Eurofins Scientific S.E. Main Business Overview
11.20.5 Eurofins Scientific S.E. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tumor NGS Detection Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Tumor NGS Detection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Medical Equipment
Table 4. Major Players of Consumables
Table 5. Tumor NGS Detection Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Tumor NGS Detection Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Tumor NGS Detection Market Size Market Share by Type (2021-2026)
Table 8. Tumor NGS Detection Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Tumor NGS Detection Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Tumor NGS Detection Market Size Market Share by Application (2021-2026)
Table 11. Global Tumor NGS Detection Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Tumor NGS Detection Revenue Market Share by Player (2021-2026)
Table 13. Tumor NGS Detection Key Players Head office and Products Offered
Table 14. Tumor NGS Detection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Tumor NGS Detection Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Tumor NGS Detection Market Size Market Share by Region (2021-2026)
Table 19. Global Tumor NGS Detection Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Tumor NGS Detection Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Tumor NGS Detection Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Tumor NGS Detection Market Size Market Share by Country (2021-2026)
Table 23. Americas Tumor NGS Detection Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Tumor NGS Detection Market Size Market Share by Type (2021-2026)
Table 25. Americas Tumor NGS Detection Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Tumor NGS Detection Market Size Market Share by Application (2021-2026)
Table 27. APAC Tumor NGS Detection Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Tumor NGS Detection Market Size Market Share by Region (2021-2026)
Table 29. APAC Tumor NGS Detection Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Tumor NGS Detection Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Tumor NGS Detection Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Tumor NGS Detection Market Size Market Share by Country (2021-2026)
Table 33. Europe Tumor NGS Detection Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Tumor NGS Detection Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Tumor NGS Detection Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Tumor NGS Detection Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Tumor NGS Detection Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Tumor NGS Detection
Table 39. Key Market Challenges & Risks of Tumor NGS Detection
Table 40. Key Industry Trends of Tumor NGS Detection
Table 41. Global Tumor NGS Detection Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Tumor NGS Detection Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Tumor NGS Detection Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Tumor NGS Detection Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Agilent Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 46. Agilent Tumor NGS Detection Product Offered
Table 47. Agilent Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Agilent Main Business
Table 49. Agilent Latest Developments
Table 50. Thermo Fisher Scientific Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 51. Thermo Fisher Scientific Tumor NGS Detection Product Offered
Table 52. Thermo Fisher Scientific Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Thermo Fisher Scientific Main Business
Table 54. Thermo Fisher Scientific Latest Developments
Table 55. BGI Group Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 56. BGI Group Tumor NGS Detection Product Offered
Table 57. BGI Group Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. BGI Group Main Business
Table 59. BGI Group Latest Developments
Table 60. Roche Foundation Medicine Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 61. Roche Foundation Medicine Tumor NGS Detection Product Offered
Table 62. Roche Foundation Medicine Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Roche Foundation Medicine Main Business
Table 64. Roche Foundation Medicine Latest Developments
Table 65. Sinopharm Group Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 66. Sinopharm Group Tumor NGS Detection Product Offered
Table 67. Sinopharm Group Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Sinopharm Group Main Business
Table 69. Sinopharm Group Latest Developments
Table 70. Fosunpharma Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 71. Fosunpharma Tumor NGS Detection Product Offered
Table 72. Fosunpharma Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Fosunpharma Main Business
Table 74. Fosunpharma Latest Developments
Table 75. Novogene Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 76. Novogene Tumor NGS Detection Product Offered
Table 77. Novogene Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Novogene Main Business
Table 79. Novogene Latest Developments
Table 80. Geneseeq Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 81. Geneseeq Tumor NGS Detection Product Offered
Table 82. Geneseeq Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Geneseeq Main Business
Table 84. Geneseeq Latest Developments
Table 85. AmoyDx Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 86. AmoyDx Tumor NGS Detection Product Offered
Table 87. AmoyDx Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. AmoyDx Main Business
Table 89. AmoyDx Latest Developments
Table 90. Burning Rock Medicine Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 91. Burning Rock Medicine Tumor NGS Detection Product Offered
Table 92. Burning Rock Medicine Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Burning Rock Medicine Main Business
Table 94. Burning Rock Medicine Latest Developments
Table 95. Perkin Elmer Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 96. Perkin Elmer Tumor NGS Detection Product Offered
Table 97. Perkin Elmer Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Perkin Elmer Main Business
Table 99. Perkin Elmer Latest Developments
Table 100. Qiagen NV Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 101. Qiagen NV Tumor NGS Detection Product Offered
Table 102. Qiagen NV Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Qiagen NV Main Business
Table 104. Qiagen NV Latest Developments
Table 105. Partek Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 106. Partek Tumor NGS Detection Product Offered
Table 107. Partek Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Partek Main Business
Table 109. Partek Latest Developments
Table 110. Illumina Inc. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 111. Illumina Inc. Tumor NGS Detection Product Offered
Table 112. Illumina Inc. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Illumina Inc. Main Business
Table 114. Illumina Inc. Latest Developments
Table 115. Pacific Biosciences of California Inc. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 116. Pacific Biosciences of California Inc. Tumor NGS Detection Product Offered
Table 117. Pacific Biosciences of California Inc. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Pacific Biosciences of California Inc. Main Business
Table 119. Pacific Biosciences of California Inc. Latest Developments
Table 120. Life Technologies Corporation Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 121. Life Technologies Corporation Tumor NGS Detection Product Offered
Table 122. Life Technologies Corporation Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Life Technologies Corporation Main Business
Table 124. Life Technologies Corporation Latest Developments
Table 125. GTH.O Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 126. GTH.O Tumor NGS Detection Product Offered
Table 127. GTH.O Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. GTH.O Main Business
Table 129. GTH.O Latest Developments
Table 130. Paradigm Diagnostics Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 131. Paradigm Diagnostics Tumor NGS Detection Product Offered
Table 132. Paradigm Diagnostics Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Paradigm Diagnostics Main Business
Table 134. Paradigm Diagnostics Latest Developments
Table 135. Oxford Nanopore Technologies Ltd. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 136. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Offered
Table 137. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Oxford Nanopore Technologies Ltd. Main Business
Table 139. Oxford Nanopore Technologies Ltd. Latest Developments
Table 140. Eurofins Scientific S.E. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 141. Eurofins Scientific S.E. Tumor NGS Detection Product Offered
Table 142. Eurofins Scientific S.E. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Eurofins Scientific S.E. Main Business
Table 144. Eurofins Scientific S.E. Latest Developments
Table 1. Tumor NGS Detection Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Tumor NGS Detection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Medical Equipment
Table 4. Major Players of Consumables
Table 5. Tumor NGS Detection Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Tumor NGS Detection Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Tumor NGS Detection Market Size Market Share by Type (2021-2026)
Table 8. Tumor NGS Detection Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Tumor NGS Detection Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Tumor NGS Detection Market Size Market Share by Application (2021-2026)
Table 11. Global Tumor NGS Detection Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Tumor NGS Detection Revenue Market Share by Player (2021-2026)
Table 13. Tumor NGS Detection Key Players Head office and Products Offered
Table 14. Tumor NGS Detection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Tumor NGS Detection Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Tumor NGS Detection Market Size Market Share by Region (2021-2026)
Table 19. Global Tumor NGS Detection Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Tumor NGS Detection Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Tumor NGS Detection Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Tumor NGS Detection Market Size Market Share by Country (2021-2026)
Table 23. Americas Tumor NGS Detection Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Tumor NGS Detection Market Size Market Share by Type (2021-2026)
Table 25. Americas Tumor NGS Detection Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Tumor NGS Detection Market Size Market Share by Application (2021-2026)
Table 27. APAC Tumor NGS Detection Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Tumor NGS Detection Market Size Market Share by Region (2021-2026)
Table 29. APAC Tumor NGS Detection Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Tumor NGS Detection Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Tumor NGS Detection Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Tumor NGS Detection Market Size Market Share by Country (2021-2026)
Table 33. Europe Tumor NGS Detection Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Tumor NGS Detection Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Tumor NGS Detection Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Tumor NGS Detection Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Tumor NGS Detection Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Tumor NGS Detection
Table 39. Key Market Challenges & Risks of Tumor NGS Detection
Table 40. Key Industry Trends of Tumor NGS Detection
Table 41. Global Tumor NGS Detection Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Tumor NGS Detection Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Tumor NGS Detection Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Tumor NGS Detection Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Agilent Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 46. Agilent Tumor NGS Detection Product Offered
Table 47. Agilent Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Agilent Main Business
Table 49. Agilent Latest Developments
Table 50. Thermo Fisher Scientific Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 51. Thermo Fisher Scientific Tumor NGS Detection Product Offered
Table 52. Thermo Fisher Scientific Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Thermo Fisher Scientific Main Business
Table 54. Thermo Fisher Scientific Latest Developments
Table 55. BGI Group Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 56. BGI Group Tumor NGS Detection Product Offered
Table 57. BGI Group Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. BGI Group Main Business
Table 59. BGI Group Latest Developments
Table 60. Roche Foundation Medicine Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 61. Roche Foundation Medicine Tumor NGS Detection Product Offered
Table 62. Roche Foundation Medicine Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Roche Foundation Medicine Main Business
Table 64. Roche Foundation Medicine Latest Developments
Table 65. Sinopharm Group Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 66. Sinopharm Group Tumor NGS Detection Product Offered
Table 67. Sinopharm Group Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Sinopharm Group Main Business
Table 69. Sinopharm Group Latest Developments
Table 70. Fosunpharma Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 71. Fosunpharma Tumor NGS Detection Product Offered
Table 72. Fosunpharma Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Fosunpharma Main Business
Table 74. Fosunpharma Latest Developments
Table 75. Novogene Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 76. Novogene Tumor NGS Detection Product Offered
Table 77. Novogene Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Novogene Main Business
Table 79. Novogene Latest Developments
Table 80. Geneseeq Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 81. Geneseeq Tumor NGS Detection Product Offered
Table 82. Geneseeq Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Geneseeq Main Business
Table 84. Geneseeq Latest Developments
Table 85. AmoyDx Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 86. AmoyDx Tumor NGS Detection Product Offered
Table 87. AmoyDx Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. AmoyDx Main Business
Table 89. AmoyDx Latest Developments
Table 90. Burning Rock Medicine Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 91. Burning Rock Medicine Tumor NGS Detection Product Offered
Table 92. Burning Rock Medicine Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Burning Rock Medicine Main Business
Table 94. Burning Rock Medicine Latest Developments
Table 95. Perkin Elmer Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 96. Perkin Elmer Tumor NGS Detection Product Offered
Table 97. Perkin Elmer Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Perkin Elmer Main Business
Table 99. Perkin Elmer Latest Developments
Table 100. Qiagen NV Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 101. Qiagen NV Tumor NGS Detection Product Offered
Table 102. Qiagen NV Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Qiagen NV Main Business
Table 104. Qiagen NV Latest Developments
Table 105. Partek Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 106. Partek Tumor NGS Detection Product Offered
Table 107. Partek Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Partek Main Business
Table 109. Partek Latest Developments
Table 110. Illumina Inc. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 111. Illumina Inc. Tumor NGS Detection Product Offered
Table 112. Illumina Inc. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Illumina Inc. Main Business
Table 114. Illumina Inc. Latest Developments
Table 115. Pacific Biosciences of California Inc. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 116. Pacific Biosciences of California Inc. Tumor NGS Detection Product Offered
Table 117. Pacific Biosciences of California Inc. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Pacific Biosciences of California Inc. Main Business
Table 119. Pacific Biosciences of California Inc. Latest Developments
Table 120. Life Technologies Corporation Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 121. Life Technologies Corporation Tumor NGS Detection Product Offered
Table 122. Life Technologies Corporation Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Life Technologies Corporation Main Business
Table 124. Life Technologies Corporation Latest Developments
Table 125. GTH.O Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 126. GTH.O Tumor NGS Detection Product Offered
Table 127. GTH.O Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. GTH.O Main Business
Table 129. GTH.O Latest Developments
Table 130. Paradigm Diagnostics Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 131. Paradigm Diagnostics Tumor NGS Detection Product Offered
Table 132. Paradigm Diagnostics Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Paradigm Diagnostics Main Business
Table 134. Paradigm Diagnostics Latest Developments
Table 135. Oxford Nanopore Technologies Ltd. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 136. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Offered
Table 137. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Oxford Nanopore Technologies Ltd. Main Business
Table 139. Oxford Nanopore Technologies Ltd. Latest Developments
Table 140. Eurofins Scientific S.E. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 141. Eurofins Scientific S.E. Tumor NGS Detection Product Offered
Table 142. Eurofins Scientific S.E. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Eurofins Scientific S.E. Main Business
Table 144. Eurofins Scientific S.E. Latest Developments
LIST OF FIGURES
Figure 1. Tumor NGS Detection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tumor NGS Detection Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Tumor NGS Detection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Tumor NGS Detection Sales Market Share by Country/Region (2025)
Figure 8. Tumor NGS Detection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Tumor NGS Detection Market Size Market Share by Type in 2025
Figure 10. Tumor NGS Detection in Companion Diagnostics
Figure 11. Global Tumor NGS Detection Market: Companion Diagnostics (2021-2026) & ($ millions)
Figure 12. Tumor NGS Detection in Early Cancer Screening
Figure 13. Global Tumor NGS Detection Market: Early Cancer Screening (2021-2026) & ($ millions)
Figure 14. Tumor NGS Detection in Drug Discovery
Figure 15. Global Tumor NGS Detection Market: Drug Discovery (2021-2026) & ($ millions)
Figure 16. Tumor NGS Detection in Other
Figure 17. Global Tumor NGS Detection Market: Other (2021-2026) & ($ millions)
Figure 18. Global Tumor NGS Detection Market Size Market Share by Application in 2025
Figure 19. Global Tumor NGS Detection Revenue Market Share by Player in 2025
Figure 20. Global Tumor NGS Detection Market Size Market Share by Region (2021-2026)
Figure 21. Americas Tumor NGS Detection Market Size 2021-2026 ($ millions)
Figure 22. APAC Tumor NGS Detection Market Size 2021-2026 ($ millions)
Figure 23. Europe Tumor NGS Detection Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Tumor NGS Detection Market Size 2021-2026 ($ millions)
Figure 25. Americas Tumor NGS Detection Value Market Share by Country in 2025
Figure 26. United States Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Tumor NGS Detection Market Size Market Share by Region in 2025
Figure 31. APAC Tumor NGS Detection Market Size Market Share by Type (2021-2026)
Figure 32. APAC Tumor NGS Detection Market Size Market Share by Application (2021-2026)
Figure 33. China Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 37. India Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Tumor NGS Detection Market Size Market Share by Country in 2025
Figure 40. Europe Tumor NGS Detection Market Size Market Share by Type (2021-2026)
Figure 41. Europe Tumor NGS Detection Market Size Market Share by Application (2021-2026)
Figure 42. Germany Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 43. France Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Tumor NGS Detection Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Tumor NGS Detection Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Tumor NGS Detection Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 56. APAC Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 57. Europe Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 59. United States Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 60. Canada Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 61. Mexico Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 62. Brazil Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 63. China Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 64. Japan Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 65. Korea Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 67. India Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 68. Australia Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 69. Germany Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 70. France Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 71. UK Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 72. Italy Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 73. Russia Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 74. Egypt Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 75. South Africa Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 76. Israel Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 77. Turkey Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 78. Global Tumor NGS Detection Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Tumor NGS Detection Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 1. Tumor NGS Detection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tumor NGS Detection Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Tumor NGS Detection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Tumor NGS Detection Sales Market Share by Country/Region (2025)
Figure 8. Tumor NGS Detection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Tumor NGS Detection Market Size Market Share by Type in 2025
Figure 10. Tumor NGS Detection in Companion Diagnostics
Figure 11. Global Tumor NGS Detection Market: Companion Diagnostics (2021-2026) & ($ millions)
Figure 12. Tumor NGS Detection in Early Cancer Screening
Figure 13. Global Tumor NGS Detection Market: Early Cancer Screening (2021-2026) & ($ millions)
Figure 14. Tumor NGS Detection in Drug Discovery
Figure 15. Global Tumor NGS Detection Market: Drug Discovery (2021-2026) & ($ millions)
Figure 16. Tumor NGS Detection in Other
Figure 17. Global Tumor NGS Detection Market: Other (2021-2026) & ($ millions)
Figure 18. Global Tumor NGS Detection Market Size Market Share by Application in 2025
Figure 19. Global Tumor NGS Detection Revenue Market Share by Player in 2025
Figure 20. Global Tumor NGS Detection Market Size Market Share by Region (2021-2026)
Figure 21. Americas Tumor NGS Detection Market Size 2021-2026 ($ millions)
Figure 22. APAC Tumor NGS Detection Market Size 2021-2026 ($ millions)
Figure 23. Europe Tumor NGS Detection Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Tumor NGS Detection Market Size 2021-2026 ($ millions)
Figure 25. Americas Tumor NGS Detection Value Market Share by Country in 2025
Figure 26. United States Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Tumor NGS Detection Market Size Market Share by Region in 2025
Figure 31. APAC Tumor NGS Detection Market Size Market Share by Type (2021-2026)
Figure 32. APAC Tumor NGS Detection Market Size Market Share by Application (2021-2026)
Figure 33. China Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 37. India Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Tumor NGS Detection Market Size Market Share by Country in 2025
Figure 40. Europe Tumor NGS Detection Market Size Market Share by Type (2021-2026)
Figure 41. Europe Tumor NGS Detection Market Size Market Share by Application (2021-2026)
Figure 42. Germany Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 43. France Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Tumor NGS Detection Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Tumor NGS Detection Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Tumor NGS Detection Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Tumor NGS Detection Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 56. APAC Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 57. Europe Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 59. United States Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 60. Canada Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 61. Mexico Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 62. Brazil Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 63. China Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 64. Japan Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 65. Korea Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 67. India Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 68. Australia Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 69. Germany Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 70. France Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 71. UK Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 72. Italy Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 73. Russia Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 74. Egypt Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 75. South Africa Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 76. Israel Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 77. Turkey Tumor NGS Detection Market Size 2027-2032 ($ millions)
Figure 78. Global Tumor NGS Detection Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Tumor NGS Detection Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Tumor NGS Detection Market Size 2027-2032 ($ millions)
